LeMaitre Vascular, Inc. (LMAT) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

LeMaitre Vascular, Inc. (LMAT) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

LMAT

Market Closed

LeMaitre Vascular, Inc.

NASDAQHealthcare Medical - Instruments & Supplies

655 employees

CEO: George W. LeMaitre

Founded: 2006

$99.10

+$0.00(+NaN%)

Market Cap

2.26B

Beta

0.52

52W Range

N/A

Dividend Yield

0.91%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

71.5%

18.3%

CAGR: 15.2%

Profit after direct costs

Operating Margin

27.2%

30.0%

CAGR: 16.9%

Core business profitability

Net Margin

23.1%

31.1%

CAGR: 21.0%

Bottom line profitability

Revenue Growth

13.5%

YoY

CAGR: 12.8%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how LMAT allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

71.5%

$178.54M

Operating Margin

27.2%

$67.91M

Net Margin

23.1%

$57.73M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	154.42M	161.65M	193.48M	219.86M	249.60M	13.5%
Cost of Revenue	(53.04M)	(56.76M)	(66.44M)	(68.96M)	(71.06M)	3.0%
Gross Profit	101.38M	104.90M	127.05M	150.90M	178.54M	18.3%
Operating Expenses
Research & Development	(11.80M)	(13.29M)	(16.97M)	(15.65M)	(14.14M)	-9.7%
Selling, General & Administrative	(53.16M)	(61.67M)	(72.89M)	(83.00M)	(96.49M)	16.3%
General & Administrative	(25.50M)	(28.75M)	(31.83M)	(36.26M)	(42.02M)	15.9%
Selling & Marketing	(27.66M)	(32.92M)	(41.05M)	(46.74M)	(54.46M)	16.5%
Depreciation & Amortization	(9.47M)	(9.43M)	(9.52M)	(9.67M)	(10.42M)	7.7%
Operating Income (EBIT)	36.42M	26.83M	36.71M	52.26M	67.91M	30.0%
Non-Operating Items
Interest Income	197.00K	986.00K	3.08M	4.95M	13.09M	164.6%
Interest Expense	(2.22M)	—	—	(205.00K)	(5.18M)	2428.8%
Other Income/Expenses (Net)	-2.14M	661.00K	2.76M	4.62M	7.27M	57.4%
Income Before Tax	34.29M	27.49M	39.48M	56.88M	75.18M	32.2%
Income Tax Expense	(7.38M)	(6.85M)	(9.37M)	(12.84M)	(17.45M)	35.9%
Net Income	26.91M	20.64M	30.11M	44.04M	57.73M	31.1%
Per Share Metrics
Earnings Per Share (Basic)	$1	$1	$1	$2	$3	30.1%
Weighted Avg Shares Outstanding	21.16M	21.98M	22.22M	22.45M	22.64M	0.8%
Weighted Avg Shares Outstanding (Diluted)	21.48M	22.17M	22.42M	22.78M	22.93M	0.7%
EBITDA	45.98M	36.92M	48.99M	66.75M	90.79M	36.0%

Explore LMAT

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

LMAT in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →